Global law firm Norton Rose Fulbright announced today that it has appointed partners Stacey Martinez and Randy Sutton as joint global heads of life sciences and healthcare. Martinez and Sutton will be responsible for promoting the firm’s life sciences and healthcare strategy and guiding the group of more than 400 lawyers and professionals globally.
Martinez, who previously served as partner-in-charge of the firm’s Austin office, focuses her practice on pharmaceutical and medical device matters, product liability, class actions and cases involving exposure to toxic substances.
Sutton, who leads the firm’s life sciences and healthcare group in Canada, has worked extensively with a broad range of life science and healthcare clients in litigation and regulatory matters.
Peter Martyr, Norton Rose Fulbright’s Global Chief Executive, said:
“Stacey and Randy have excelled as leaders within their regions, and we are delighted to expand their responsibilities globally. Both have proven themselves to be fantastic collaborators, and we look forward to them working together to grow our life sciences and healthcare practice.”
Martinez, who also serves on the US Management Committee, commented:
“To be entrusted with this role is a tremendous honor, and I look forward to maximizing all that our life sciences and healthcare group has to offer. We have tremendous opportunities to service our global clients facing complex legal issues on a variety of regulatory, transaction and litigation matters.”
Sutton, partner and co-chair of the firm’s class actions team in Canada, said:
“I am thrilled to have been asked to take on this leadership opportunity within this important industry group. Norton Rose Fulbright’s comprehensive service offering to the life sciences and healthcare sector continues to allow us to respond to our client’s changing needs in an increasingly competitive environment.”
Norton Rose Fulbright’s global life sciences and healthcare team provides a full range of legal advice to pharmaceutical, medical device and biotechnology companies, healthcare providers along with industry investors.